The Patent Finder

Lung Cancer Proteomics LLC

6 patents currently held · Updated Nov 18, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3
Ending by 2030
Oct 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 26, 2027
    The maintenance fee for Plasma Based Protein Profiling for Early Stage Lung Cancer Diagnosis (US 11,769,596) comes due Mar 26, 2027. Unpaid by Sep 27, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 6 of 6

PatentTitleStatus Expires Confidence
US 11,474,104Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,888,051Method of identifying biomarkers in human serum indicative of pathologies of human lung tissues
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,933,429Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,541,183Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,952,220Methods of Identification and Diagnosis of Lung Diseases Using Classification Systems and Kits Thereof
In force
 · High confidence
In forceHigh confidence
US 11,769,596Plasma Based Protein Profiling for Early Stage Lung Cancer Diagnosis
In force
 · High confidence
In forceHigh confidence

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited